Jpmorgan Chase & CO Penumbra Inc Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Penumbra Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 314,955 shares of PEN stock, worth $72.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
314,955
Previous 102,610
206.94%
Holding current value
$72.3 Million
Previous $22.9 Million
147.52%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding PEN
# of Institutions
382Shares Held
29.6MCall Options Held
285KPut Options Held
168K-
Black Rock Inc. New York, NY4.26MShares$977 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.7MShares$848 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.03MShares$694 Million0.07% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.28MShares$295 Million1.46% of portfolio
-
State Street Corp Boston, MA1.23MShares$283 Million0.01% of portfolio
About Penumbra Inc
- Ticker PEN
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,888,400
- Market Cap $8.7B
- Description
- Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...